Maternal & Reproductive Health Conference · 2026-05-10 · Pediatrics

Early Detection and Prevention of Cervical Cancer in Women of Reproductive Age

Tajimuratova Iroda Ruzmatovna
2nd year clinical residency students of the Department of Obstetrics and Gynecology of Samarkand State Medical University

View on AAMS · All conferences

Abstract

Cervical cancer remains one of the leading causes of cancer-related morbidity and mortality among women of reproductive age worldwide. Persistent infection with high-risk human papillomavirus (HPV) is considered the main etiological factor in the development of cervical intraepithelial neoplasia and invasive cervical carcinoma. Early detection through screening programs and preventive strategies significantly reduces disease incidence and improves survival rates. This study evaluated modern approaches to the early diagnosis and prevention of cervical cancer in reproductive-age women, focusing on cytological screening, HPV testing, vaccination, and preventive gynecological care. The findings demonstrated that comprehensive screening and vaccination programs contribute to earlier detection of precancerous lesions and significantly decrease the risk of cervical cancer progression.

Keywords: cervical cancer, HPV, cervical screening, Pap smear, HPV vaccination, reproductive-age women, early diagnosis, gynecology

Cervical cancer continues to represent a major public health problem, especially in low- and middle-income countries where access to screening and vaccination remains limited. Persistent infection with oncogenic HPV strains leads to progressive epithelial dysplasia and malignant transformation of cervical cells. Many women remain asymptomatic during early stages of the disease, resulting in delayed diagnosis and reduced treatment effectiveness. Modern preventive strategies, including Pap smear cytology, HPV DNA testing, colposcopy, and prophylactic HPV vaccination, have significantly improved early detection and prevention of cervical malignancy. Understanding the importance of organized screening programs and preventive healthcare measures is essential for reducing disease burden and improving women’s reproductive health.

The aim of the study was to evaluate the effectiveness of modern methods for early detection and prevention of cervical cancer in women of reproductive age and to assess their impact on reducing the incidence of precancerous and malignant cervical lesions.

The study included 120 women aged 20–45 years who attended gynecological clinics for routine reproductive health evaluation. All participants underwent gynecological examination, cervical cytology (Pap smear), HPV DNA testing, and colposcopic assessment when indicated. Patients with abnormal cytological findings underwent biopsy and histopathological examination. Preventive measures included HPV vaccination counseling, reproductive health education, and regular screening follow-up. Statistical analysis was performed to evaluate the prevalence of cervical abnormalities, HPV infection rates, and the effectiveness of preventive interventions.

The study demonstrated that combined use of Pap smear cytology and HPV DNA testing significantly improved the early detection of cervical epithelial abnormalities. High-risk HPV strains were identified in a substantial proportion of women with cervical dysplasia. Colposcopic examination enabled accurate localization and assessment of precancerous lesions. Women participating in regular screening programs showed significantly lower rates of advanced cervical pathology compared to unscreened individuals. Preventive vaccination against HPV was associated with reduced prevalence of high-risk viral infection and lower incidence of cervical intraepithelial neoplasia. Educational counseling improved awareness regarding reproductive health, cancer prevention, and the importance of regular gynecological examinations.

Early detection and prevention strategies play a crucial role in reducing the incidence and mortality of cervical cancer among women of reproductive age. Combined screening methods, including Pap smear cytology and HPV testing, provide high diagnostic effectiveness for identifying precancerous lesions at early stages. HPV vaccination and regular gynecological monitoring significantly contribute to cervical cancer prevention and improved reproductive health outcomes. Expansion of screening programs and public health education remains essential for effective control of cervical cancer worldwide.

1. World Health Organization. Comprehensive cervical cancer control: a guide to essential practice. WHO Press; 2021.

2. Arbyn M., Weiderpass E., Bruni L., et al. Estimates of incidence and mortality of cervical cancer worldwide. Lancet Glob Health. 2020;8(2):e191–e203.

3. Bosch F.X., Lorincz A., Muñoz N., et al. The causal relation between HPV and cervical cancer. J Clin Pathol. 2002;55(4):244–265.

4. Schiffman M., Castle P.E., Jeronimo J., et al. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890–907.

5. Saslow D., Solomon D., Lawson H.W., et al. Screening guidelines for cervical cancer prevention. CA Cancer J Clin. 2012;62(3):147–172.

6. Crosbie E.J., Einstein M.H., Franceschi S., Kitchener H.C. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889–899.

7. Bruni L., Albero G., Serrano B., et al. Human papillomavirus and related diseases report. ICO/IARC Information Centre on HPV and Cancer; 2021.

8. Winer R.L., Hughes J.P., Feng Q., et al. Effectiveness of HPV vaccination. N Engl J Med. 2015;372(8):711–723.

9. med1.uz — educational resources on gynecology and women’s reproductive health.

10. Canfell K. Towards elimination of cervical cancer. Lancet Public Health. 2019;4(1):e19–e20.